Mikhail Groubman joined Atlant Clinical as Chief Executive Officer in 2012. He has led the company from local niche CRO to become one of the principal international providers of clinical studies and support services within the healthcare industry. Prior to Atlant Clinical, he was at GlaxoSmithKline, where he worked in a variety of leadership positions within Sales and Market Access groups.